FIM
BLUE

Fernwood Investment Management’s bluebird bio BLUE Stock Holding History

Fernwood Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$2.56K – 251
2024
Q1 		$2.56K Buy
+100
New +$2.56K ﹤0.01% 665

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fernwood Investment Management's BLUE Position: Q2 2024 in Review

Fernwood Investment Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 100 shares — an estimated $2.56K sold.

Fernwood Investment Management first reported a position in BLUE in Q1 2024 and held it in 1 quarter. The position peaked at $2.56K in Q1 2024. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Fernwood Investment Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 100 bluebird bio shares in Q2 2024, an estimated $2.56K.
  • Fernwood Investment Management first reported a position in bluebird bio in Q1 2024 and held it in 1 quarter.
  • Fernwood Investment Management's bluebird bio position peaked at $2.56K in Q1 2024.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.